The Hospice Industries Fraud Crisis Just Got a Reckoning: Reading the FY 2027 CMS Proposed Rule Against the Backdrop of Operation Never Say Die

Key Takeaways

• CMS proposes 2.4% hospice payment increase, $785 M extra.
• Non‑hospice Medicare spending rose to $2.8 B in FY 2024.
• For‑profit hospices spend 167% more outside the benefit.
• New SSVI scorecard flags providers with fraud risk signals.
• Mandatory election addendum aims to improve patient transparency.

Summary

CMS released a FY 2027 hospice wage index and payment rate update proposing a 2.4% increase that would add roughly $785 million in Medicare payments. The rule arrives days after the Operation Never Say Die arrests, which uncovered a $60 million fraud ring and an estimated $3.5 billion in fraudulent reimbursements in Los Angeles County. It also highlights a surge in non‑hospice Medicare spending to over $2.8 billion and a stark 167% higher outside‑benefit cost for for‑profit hospices. New tools like the Service and Spending Variation Index (SSVI) and a mandatory election addendum aim to tighten oversight and transparency.

Pulse Analysis

The timing of CMS's FY 2027 hospice payment update underscores a strategic response to a growing fraud epidemic. By aligning the proposed 2.4% increase with a robust data‑driven oversight framework, the agency seeks to balance higher reimbursement rates against the need for tighter program integrity. This move follows the high‑profile Operation Never Say Die takedown, which exposed systemic abuse in Southern California and highlighted how vulnerable the hospice benefit can be to exploitation. Stakeholders now face a regulatory environment that demands greater transparency and accountability.

Beyond the headline payment bump, the rule draws attention to an alarming rise in non‑hospice Medicare expenditures. Spending on services outside the hospice per‑diem leapt from $790 million in FY 2020 to more than $2.8 billion in FY 2024, driven largely by for‑profit operators whose outside billing is 167% higher than that of non‑profits. This disparity signals a profit‑driven incentive structure that inflates costs and jeopardizes patient care quality. Policymakers are therefore pushing for reforms—such as the mandatory election addendum—to ensure beneficiaries understand coverage limits and can flag inappropriate charges.

The introduction of the Service and Spending Variation Index (SSVI) provides a quantifiable fraud‑risk score for each hospice, leveraging nine claims‑based metrics, with non‑hospice spending carrying the most weight. This publicly available score creates a new data asset for investors, health‑tech firms, and payers seeking to assess provider risk and guide M&A decisions. Simultaneously, the proposed mandatory election statement forces providers to embed compliance workflows into intake processes, opening opportunities for vendors that specialize in electronic documentation and patient education. Together, these initiatives signal a shift toward data‑centric oversight that could reshape the hospice market’s financial dynamics and investment landscape.